Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. (Record no. 27123927)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02627 a2200793 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517152046.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201803s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1569-8041 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1093/annonc/mdx031 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Mato, A R |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180302 |
| 245 00 - TITLE STATEMENT | |
| Title | Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Annals of oncology : official journal of the European Society for Medical Oncology |
| Date of publication, distribution, etc. | 05 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1050-1056 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Multicenter Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adenine |
| General subdivision | analogs & derivatives |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bridged Bicyclo Compounds, Heterocyclic |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukemia, Lymphocytic, Chronic, B-Cell |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Piperidines |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proportional Hazards Models |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Purines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrazoles |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrimidines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Quinazolinones |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Retrospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulfonamides |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hill, B T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lamanna, N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barr, P M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ujjani, C S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brander, D M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Howlett, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Skarbnik, A P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cheson, B D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zent, C S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pu, J J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kiselev, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Foon, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lenhart, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Henick Bachow, S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Winter, A M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cruz, A-L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Claxton, D F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Goy, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Daniel, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Isaac, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kennard, K H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Timlin, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fanning, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gashonia, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yacur, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Svoboda, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schuster, S J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nabhan, C |
| 773 0# - HOST ITEM ENTRY | |
| Title | Annals of oncology : official journal of the European Society for Medical Oncology |
| Related parts | vol. 28 |
| -- | no. 5 |
| -- | p. 1050-1056 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1093/annonc/mdx031">https://doi.org/10.1093/annonc/mdx031</a> |
| Public note | Available from publisher's website |
No items available.